Dr. Glenn Hanna, Director, Center for Salivary and Rare Head and Neck Cancers at Dana-Farber Cancer Institute, discusses NavDx®, a clinically validated circulating tumor tissue modified viral (TTMV) - HPV DNA test that aids in the detection of HPV-driven cancer.
To see more videos related to NavDx visit navdx.com
Ещё видео!